Published on 21 November 2024
Months away from potentially developing pancreatic cancer, a father’s life has been saved by a research study part funded by Cheshire and Merseyside Cancer Alliance.
Adam Eshborn, a 51-year-old dad of two joined a pioneering cancer research study, EUROPAC, after finding out he has a hereditary pancreatic condition.
The EUROPAC programme began registering family groups in 1997 with a history of pancreatic cancer or inherited pancreatic conditions. The registry – which is given funding by Cheshire and Merseyside Cancer Alliance – records data from family groups who suffer from hereditary pancreatic diseases or have several family members who have died from pancreatic cancer.
Professor Christopher Halloran, Honorary Consultant Pancreatic Surgeon at Royal Liverpool University Hospital, said: “EUROPAC along with its partners, NHS England, Pancreatic Cancer UK, Cheshire and Merseyside Cancer Alliance, the University of Liverpool and the Royal Liverpool University Hospital, have developed systems with national reach to find treatable pancreatic lesions before they develop into cancer.
“Adam’s story is a great example of the benefits of this programme, and how we can help save lives of people who could face this condition.”
Read the full story here: https://www.uhliverpool.nhs.uk/about-us/our-stories/fathers-life-has-been-saved-thanks-research-trial-detect-and-prevent-pancreatic-cancer
To find out if you are at an increased risk of inheriting the disease and eligible to be part of the EUROPAC registry, you can use Pancreatic Cancer UK’s History Checker: Family History Checker - Pancreatic Cancer UK